Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
HBM Holdings Ltd. ( (HK:2142) ) has shared an update.
HBM Holdings Ltd. has reported strong business performance for the year ended December 31, 2024, with expected profits ranging from RMB7.3 million to RMB22 million, and a cash profit reaching a historical high of RMB220 million. This success is attributed to strategic partnerships, growing recurring revenue, and efficient cost management. The company has repurchased shares worth nearly HK$30 million, reflecting confidence in its business outlook and indicating a perceived undervaluation of its shares.
More about HBM Holdings Ltd.
HBM Holdings Ltd. operates in the biotech industry and focuses on developing innovative solutions in partnership with global pharmaceutical and biotech companies. The company is known for its Harbour Mice® platform and has advanced over 19 molecules to the IND stage globally.
YTD Price Performance: 128.49%
Average Trading Volume: 5,167,415
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$3.21B
For a thorough assessment of 2142 stock, go to TipRanks’ Stock Analysis page.